Related Experiment Video
Updated: Jul 3, 2026

Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3
Published on: August 17, 2011
Linking calcium-channel isoforms to potential therapies.
Francesco Belardetti1, Gerald W Zamponi
1Neuromed Pharmaceuticals, Vancouver, Canada.
Voltage-gated calcium channels are crucial for cardiovascular and nervous system functions. Research is advancing novel therapeutics targeting these channels for pain, epilepsy, and cardiovascular disorders.
Area of Science:
- Pharmacology and Physiology
- Cardiovascular Research
- Neuroscience
Background:
- Voltage-gated calcium channels (VGCCs) play vital roles in physiological processes.
- Dysfunction of VGCCs is implicated in neurological and cardiovascular diseases.
- VGCCs are established therapeutic targets for various conditions.
Purpose of the Study:
- To review recent advancements in the development of calcium channel therapeutics.
- To focus on therapeutic applications in pain, epilepsy, and cardiovascular disorders.
- To highlight the potential of novel calcium channel modulators.
Main Methods:
- Literature review of recent research and clinical trials.
- Analysis of drug discovery efforts for calcium channel modulators.
- Synthesis of findings related to therapeutic efficacy and safety.
Main Results:
- Significant progress has been made in identifying and developing VGCC modulators.
- Several novel compounds show promise for treating absence epilepsy and hypertension.
- Emerging therapeutics are being explored for managing chronic pain conditions.
Conclusions:
- Calcium channel therapeutics represent a promising area for treating neurological and cardiovascular diseases.
- Continued research into novel calcium channel modulators is essential for addressing unmet medical needs.
- Targeting VGCCs offers a viable strategy for developing effective treatments for pain, epilepsy, and cardiovascular dysfunction.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...

